STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLLS
  4. [EFFECT] Cellectis S.A. American SEC Filing

[EFFECT] Cellectis S.A. American SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:00 P.M.
Form: F-3
CIK: 0001627281
Company Name: Cellectis S.A.
File Number: 333-288491

Source: View Original Filing on SEC EDGAR

Stock CLLS logo
Cellectis

NASDAQ:CLLS

CLLS Rankings

#3568 Ranked by Market Cap
N/A Ranked by Dividends

CLLS Latest News

Oct 7, 2025
Monthly information on share capital and company voting rights
Oct 7, 2025
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress
Sep 3, 2025
Monthly information on share capital and company voting rights
Aug 7, 2025
Monthly information on share capital and company voting rights
Aug 4, 2025
Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

CLLS Latest SEC Filings

Oct 7, 2025
[6-K] Cellectis S.A. Current Report (Foreign Issuer)
Aug 4, 2025
[6-K] Cellectis S.A. American Current Report (Foreign Issuer)
Aug 4, 2025
[6-K] Cellectis S.A. American Current Report (Foreign Issuer)
Jul 28, 2025
[6-K] Cellectis S.A. American Current Report (Foreign Issuer)
Jul 2, 2025
[F-3] Cellectis S.A. American Foreign Issuer Shelf Registration

CLLS Stock Data

418.36M
72.33M
3.85%
18.77%
0.21%
Biotechnology
Healthcare
Link
France
Paris